RasmussenM, MøllerFT, GunalanV, et al.First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023. Euro Surveill, 2023; 28(36):2300460; doi: 10.2807/1560-7917.ES.2023.28.36
2.
MahaseE. Covid-19: New “Pirola” variant BA.2.86 continues to spread in UK and US. BMJ, 2023; 382:2097; doi: 10.1136/bmj.p2097
3.
PooleyN, Abdool KarimSS, CombadièreB, et al.Durability of vaccine-induced and natural immunity against COVID-19: A narrative review. Infect Dis Ther, 2023; 12(2):367–387; doi: 10.1007/s40121-022-00753-2
4.
DianiS, LeonardiE, CavezziA, et al.SARS-CoV-2-the role of natural immunity: A narrative review. J Clin Med. 2022; 11(21):6272; doi: 10.3390/jcm11216272
5.
BuckAM, DeitchmanAN, TakahashiS, et al.The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of long COVID symptoms. medRxiv, 2023;2023.03.30.23287923.
6.
The UK government needs to expand covid-19 vaccination this winter. BMJ, 2023; 382:2006; doi: 10.1136/bmj.p2006
7.
OsterME, ShayDK, SuJR, et al.Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA, 2022; 327(4):331–340; doi: 10.1001/jama.2021.24110
8.
FraimanJ, ErvitiJ, JonesM, et al.Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine, 2022; 40(40):5798–5805; doi: 10.1016/j.vaccine.2022.08.036
